Brief: TRACON Pharmaceuticals, Inc. Q2 basic EPS USD -0.2
14/08/2023 22:15
Aug 14 (Reuters) - TRACON Pharmaceuticals, Inc. Q2 operating expenses USD 9.779 million. * Q2 basic EPS USD -0.2 * Q2 net income USD -6.286 million * Q2 income from operations USD -779 thousand
Recent news on TRACON Pharmaceuticals
See all newsBrief: TRACON Pharmaceuticals Says ENVASARC Trial ORR Is 5%, Does Not Meet 11% Endpoint
Tracon Pharmaceuticals Inc Reports Results For The Quarter Ended In March: Earnings Summary
Tracon Pharmaceuticals Inc Expected To Post A Loss Of $1.19 A Share: Earnings Preview
Tracon Pharmaceuticals Inc Expected To Post A Loss Of $1.19 A Share: Earnings Preview
Brief: Tracon Pharmaceuticals Files For Offering Of Common Stock, Pre-Funded Warrants